Press Releases :: ContraFect Corporation (CFRX)

Press Releases

Investors & Media

ContraFect Corporation Announces Closing of Initial Public Offering

August 4, 2014

ContraFect Announces Pricing of Its Initial Public Offering

July 29, 2014

Journal of Infectious Diseases Publishes ContraFect Corporation's Scientific Research

May 13, 2014

ContraFect Corporation Confirms Appointment of Julia P. Gregory as CEO and Director, and Appoints David N. Low, Michael J. Otto and Roger J. Pomerantz to Board of Directors

April 24, 2014

ContraFect Announces Management Team Changes

November 21, 2013

ContraFect Corporation to Present at 12th Annual BIO Investor Forum

October 1, 2013

ContraFect to Present at the 2013 Stifel Healthcare Conference

September 5, 2013

ContraFect Completes $11.8 Million Financing

September 4, 2013

ContraFect Corporation Showcases CF-301 at ICAAC 2013 Meeting in Denver, CO

August 22, 2013

ContraFect to Present at the 5th Annual Biotech Showcase

January 4, 2013